Fraser Bocell

Fraser Bocell

Company: Critical Path Institute (C-Path)

Job title: Senior Clinical Outcomes Assessment Scientist

Seminars:

Presenter Q+A & Audience Discussion 12:30 pm

Read more

day: Conference Day Two - Track Three

Unpacking FDA’s Response to the Alpha-Synuclein Seed Amplification Assay: What Does This Mean for the Future of Parkinson’s Clinical Trials? 12:00 pm

Showcasing the latest advancements of αSyn-SAA in monitoring drug-induced improvement in PD progression Highlighting opportunities unlocked by αSyn-SAA to establish objective endpoints and monitor efficacy of PD drugsRead more

day: Conference Day Two - Track Three

Panel Discussion: Exploring Opportunities in Alpha-Synuclein & Beyond for More Transformative & Efficacious Therapies: What’s Coming Next in Parkinson’s Drug Development? 4:30 pm

Overview of trehalose and its effects as a modulator of autophagy Pharmacokinetics and brain penetration of trehalose in rodents and non-human primates Lowering the therapeutic dose of trehalose and moving into clinical developmentRead more

day: Conference Day One PM

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.